Hannu Vanhanen

5.3k total citations · 2 hit papers
63 papers, 3.8k citations indexed

About

Hannu Vanhanen is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Nutrition and Dietetics. According to data from OpenAlex, Hannu Vanhanen has authored 63 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Cardiology and Cardiovascular Medicine, 25 papers in Surgery and 14 papers in Nutrition and Dietetics. Recurrent topics in Hannu Vanhanen's work include Lipoproteins and Cardiovascular Health (15 papers), Blood Pressure and Hypertension Studies (13 papers) and Cholesterol and Lipid Metabolism (12 papers). Hannu Vanhanen is often cited by papers focused on Lipoproteins and Cardiovascular Health (15 papers), Blood Pressure and Hypertension Studies (13 papers) and Cholesterol and Lipid Metabolism (12 papers). Hannu Vanhanen collaborates with scholars based in Finland, United States and Italy. Hannu Vanhanen's co-authors include Tatu A. Miettinen, T.A. Miettinen, Erkki Vartiainen, Helena Gylling, Pekka Puska, Timo Strandberg, Lutgarde Thijs, Jan A. Staessen, Robert Fagard and John Webster and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Circulation.

In The Last Decade

Hannu Vanhanen

62 papers receiving 3.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial

1998 1.0k citations Françoise Forette, Marie‐Laure Seux et al. The Lancet profile →
Reduction of Serum Cholesterol with Sitostanol-Ester Margarine in a Mildly Hypercholesterolemic Population

1995 600 citations Tatu A. Miettinen, Hannu Vanhanen et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hannu Vanhanen Finland	25	1.4k	1.2k	714	682	528	63	3.8k
António Coca Spain	38	563 0.4×	2.9k 2.4×	735 1.0×	860 1.3×	305 0.6×	239	4.9k
Leon A. Simons Australia	41	1.9k 1.3×	1.3k 1.0×	781 1.1×	1.6k 2.4×	529 1.0×	166	5.4k
John Webster United Kingdom	25	422 0.3×	1.8k 1.5×	251 0.4×	503 0.7×	242 0.5×	63	3.0k
W. H. Birkenhäger Netherlands	30	726 0.5×	4.6k 3.7×	897 1.3×	1.9k 2.8×	453 0.9×	100	6.6k
Giovambattista Desideri Italy	46	1.2k 0.9×	1.8k 1.5×	974 1.4×	1.9k 2.7×	1.3k 2.4×	216	7.7k
Davide Grassi Italy	35	406 0.3×	675 0.6×	794 1.1×	660 1.0×	608 1.2×	92	4.5k
Roberto Fogari Italy	40	895 0.6×	3.4k 2.7×	352 0.5×	2.2k 3.3×	739 1.4×	211	5.6k
Steven G. Chrysant United States	35	604 0.4×	2.8k 2.3×	656 0.9×	1.8k 2.6×	434 0.8×	208	4.5k
Domenic Sica United States	29	942 0.7×	3.1k 2.5×	957 1.3×	1.7k 2.6×	411 0.8×	82	5.1k
John H. Contois United States	28	1.6k 1.1×	686 0.6×	247 0.3×	1.6k 2.4×	405 0.8×	49	3.5k

Countries citing papers authored by Hannu Vanhanen

Since Specialization

Citations

This map shows the geographic impact of Hannu Vanhanen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hannu Vanhanen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hannu Vanhanen more than expected).

Fields of papers citing papers by Hannu Vanhanen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hannu Vanhanen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hannu Vanhanen. The network helps show where Hannu Vanhanen may publish in the future.

Co-authorship network of co-authors of Hannu Vanhanen

This figure shows the co-authorship network connecting the top 25 collaborators of Hannu Vanhanen. A scholar is included among the top collaborators of Hannu Vanhanen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hannu Vanhanen. Hannu Vanhanen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Julkunen, Juhani, et al.. (2009). Anger expression styles and blood pressure: evidence for different pathways. Journal of Hypertension. 27(10). 1972–1979. 15 indexed citations

Julkunen, Juhani, et al.. (2008). Depressive Symptoms and Serum Lipid Fractions in Middle-Aged Men: Physiologic and Health Behavior Links. Psychosomatic Medicine. 70(9). 960–966. 24 indexed citations

Viikari, Jorma, et al.. (2006). Effects of celiprolol and simvastatin on the calculated risk of coronary heart disease (the Celisimva study). Scandinavian Cardiovascular Journal. 40(3). 160–166. 6 indexed citations

Strandberg, Timo, Veikko Salomaa, Hannu Vanhanen, Kaisu Pitkälä, & Tatu A. Miettinen. (2002). Isolated diastolic hypertension, pulse pressure, and mean arterial pressure as predictors of mortality during a follow-up of up to 32 years. Journal of Hypertension. 20(3). 399–404. 83 indexed citations

Strandberg, Timo, Veikko Salomaa, Hannu Vanhanen, & Kaisu Pitkälä. (2001). Blood pressure and mortality during an up to 32-year follow-up. Journal of Hypertension. 19(1). 35–39. 16 indexed citations

Fagard, Robert, Jan A. Staessen, Lutgarde Thijs, et al.. (2000). Response to Antihypertensive Therapy in Older Patients With Sustained and Nonsustained Systolic Hypertension. Circulation. 102(10). 1139–1144. 196 indexed citations

Seux, Marie‐Laure, F Forette, Jan A. Staessen, et al.. (1999). Treatment of isolated systolic hypertension and dementia prevention in older patients: Results of the Systolic Hypertension in Europe Trial (SYST-EUR) vascular dementia project. European Heart Journal Supplements. 1. 3 indexed citations

Sinisalo, Juha, Hannu Vanhanen, Pia Pajunen, Heikki Vapaatalo, & Markku S. Nieminen. (1999). Ursodeoxycholic acid and endothelial‐dependent, nitric oxide‐independent vasodilatation of forearm resistance arteries in patients with coronary heart disease. British Journal of Clinical Pharmacology. 47(6). 661–665. 23 indexed citations

Forette, Françoise, Marie‐Laure Seux, Jan A. Staessen, et al.. (1998). Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial. The Lancet. 352(9137). 1347–1351. 1004 indexed citations breakdown →

10.

Staessen, Jan A., Lutgarde Thijs, Leszek Bieniaszewski, et al.. (1996). Ambulatory Monitoring Uncorrected for Placebo Overestimates Long-term Antihypertensive Action. Hypertension. 27(3). 414–420. 23 indexed citations

11.

Seppänen‐Laakso, Tuulikki, Into Laakso, Peter Backlund, Hannu Vanhanen, & Jorma Viikari. (1996). Elaidic and trans-vaccenic acids in plasma phospholipids as indicators of dietary intake of 18:1 trans-fatty acids. Journal of Chromatography B Biomedical Sciences and Applications. 687(2). 371–378. 19 indexed citations

12.

Strandberg, Timo, Veikko Salomaa, V Naukkarinen, et al.. (1995). Cardiovascular morbidity and multifactorial primary prevention. Nutrition Metabolism and Cardiovascular Diseases. 5(1). 7–15. 8 indexed citations

13.

Miettinen, T.A. & Hannu Vanhanen. (1994). Serum concentration and metabolism of cholesterol during rapeseed oil and squalene feeding. American Journal of Clinical Nutrition. 59(2). 356–363. 102 indexed citations

14.

Strandberg, Timo, et al.. (1994). Associations of cholesterol lowering by statins with anger and hostility in hypercholesterolemic men. Biological Psychiatry. 35(8). 575–577. 25 indexed citations

15.

Staessen, Jan A., CJ Bulpitt, Paul De Cort, et al.. (1993). (on behalf of the Syst-Eur Investigators). Nitrendipine in older patients with isolated systolic hypertension: second progress report on the SYST-EUR trial. Journal of Human Hypertension. 7. 411–412. 4 indexed citations

16.

Vanhanen, Hannu, et al.. (1993). Replacement of Margarine on Bread by Rapeseed and Olive Oils: Effects on Plasma Fatty Acid Composition and Serum Cholesterol. Annals of Nutrition and Metabolism. 37(4). 161–174. 34 indexed citations

17.

Vanhanen, Hannu & Tatu A. Miettinen. (1992). Effects of unsaturated and saturated dietary plant sterols on their serum contents. Clinica Chimica Acta. 205(1-2). 97–107. 82 indexed citations

18.

Miettinen, T.A., Helena Gylling, Hannu Vanhanen, & A Ollus. (1992). Cholesterol absorption, elimination, and synthesis related to LDL kinetics during varying fat intake in men with different apoprotein E phenotypes.. Arteriosclerosis and Thrombosis A Journal of Vascular Biology. 12(9). 1044–1052. 155 indexed citations

19.

Vanhanen, Hannu & T. A. Miettinen. (1992). Pravastatin and lovastatin similarly reduce serum cholesterol and its precursor levels in familial hypercholesterolaemia. European Journal of Clinical Pharmacology. 42(2). 127–130. 19 indexed citations

20.

Strandberg, Timo, Hannu Vanhanen, & T.A. Miettinen. (1988). Probucol in long-term treatment of hypercholesterolemia. General Pharmacology The Vascular System. 19(3). 317–320. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact